Circulating Cell-free Genome Atlas study
See the following -
GRAIL Plans to Raise in Excess of $1B in Series B Funding
Press Release |
Illumina, Inc. |
January 5, 2017
Illumina, Inc., today announced that GRAIL has received indications of interest to invest approximately $1B for its Series B financing, primarily from undisclosed private and strategic investors. GRAIL intends to raise additional capital in the Series B financing from other investors and has engaged Goldman Sachs as a placement agent in connection with the contemplated additional financing. GRAIL intends to close the Series B prior to the end of the first quarter...
- Login to post comments